Menu
GWAS Study

Genome-wide analysis yields new loci associating with aortic valve stenosis.

Helgadottir A, Thorleifsson G, Gretarsdottir S et al.

29511194 PubMed ID
GWAS Study Type
808380 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

HA
Helgadottir A
TG
Thorleifsson G
GS
Gretarsdottir S
SO
Stefansson OA
TV
Tragante V
TR
Thorolfsdottir RB
JI
Jonsdottir I
BT
Bjornsson T
SV
Steinthorsdottir V
VN
Verweij N
NJ
Nielsen JB
ZW
Zhou W
FL
Folkersen L
MA
Martinsson A
HM
Heydarpour M
PS
Prakash S
OG
Oskarsson G
GT
Gudbjartsson T
GA
Geirsson A
OI
Olafsson I
SE
Sigurdsson EL
AP
Almgren P
MO
Melander O
FA
Franco-Cereceda A
HA
Hamsten A
FL
Fritsche L
LM
Lin M
YB
Yang B
HW
Hornsby W
GD
Guo D
BC
Brummett CM
AG
Abecasis G
MM
Mathis M
MD
Milewicz D
BS
Body SC
EP
Eriksson P
WC
Willer CJ
HK
Hveem K
NC
Newton-Cheh C
SJ
Smith JG
DR
Danielsen R
TG
Thorgeirsson G
TU
Thorsteinsdottir U
GD
Gudbjartsson DF
HH
Holm H
SK
Stefansson K
Chapter II

Abstract

Summary of the research findings

Aortic valve stenosis (AS) is the most common valvular heart disease, and valve replacement is the only definitive treatment. Here we report a large genome-wide association (GWA) study of 2,457 Icelandic AS cases and 349,342 controls with a follow-up in up to 4,850 cases and 451,731 controls of European ancestry. We identify two new AS loci, on chromosome 1p21 near PALMD (rs7543130; odds ratio (OR) = 1.20, P = 1.2 × 10-22) and on chromosome 2q22 in TEX41 (rs1830321; OR = 1.15, P = 1.8 × 10-13). Rs7543130 also associates with bicuspid aortic valve (BAV) (OR = 1.28, P = 6.6 × 10-10) and aortic root diameter (P = 1.30 × 10-8), and rs1830321 associates with BAV (OR = 1.12, P = 5.3 × 10-3) and coronary artery disease (OR = 1.05, P = 9.3 × 10-5). The results implicate both cardiac developmental abnormalities and atherosclerosis-like processes in the pathogenesis of AS. We show that several pathways are shared by CAD and AS. Causal analysis suggests that the shared risk factors of Lp(a) and non-high-density lipoprotein cholesterol contribute substantially to the frequent co-occurence of these diseases.

2,457 Icelandic ancestry cases, 349,342 Icelandic ancestry controls (including non-array genotyped, whole genome imputed individuals)

Chapter III

Study Statistics

Key metrics and study information

808380
Total Participants
GWAS
Study Type
Yes
Replicated
4,850 European ancestry cases, 451,731 European ancestry controls
Replication Participants
European
Ancestry
Iceland, U.S., Norway, Sweden, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.